Dabigatran Recalled Over Potential Carcinogen ...Middle East

Ascend Labs issues voluntary nationwide recall of dabigatran etexilate capsules (75/150 mg) after detection of unacceptable levels of a nitrosamine impurity. News Alerts

Hence then, the article about dabigatran recalled over potential carcinogen was published today ( Thursday 23/03/2023 - 10:32 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Dabigatran Recalled Over Potential Carcinogen )

Also on site :

• Casting News: The White Lotus Adds Max Greenfield And Four More, Last Of Us Casts Abby's Dad, And More
• Amazon's ‘Supportive’ Skechers Wedge Sandals Are ‘Great for Traveling’ and Just $31 Before the Big Spring Sale
• Beloved Singer-Songwriter Behind the Defining Rock Anthem of the 2000s Turns 51